Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Rubric Capital Management Reports In 13D Filing A 9.9% Stake In Heron Therapeutics

News

Rubric Capital Management Reports In 13D Filing A 9.9% Stake In Heron Therapeutics

-SEC Filing

byBenzinga Newsdesk

February 6, 2023

1 minute read

-SEC Filing

XS Financial Enters Into Upsized $39M Credit Facility With Needham Bank

By Joana Scopel

December 22, 4:43 PM

XS Financial Inc.(CSE: XSF)(OTCQB: XSHLF), a specialty finance company providing CAPEX and equipment financing solutions to US cannabis companies which recently reported its

CSE:XSF

Canadian Pacific Kansas Provides Multi-Year Guidance; Plans New Direct CP-CSX Interchange Connection In Alabama

By Akanksha Bakshi

June 28, 10:28 AM

Canadian Pacific Kansas City Ltd (NYSE: CP) issued new multi-year guidance as part of its

Truist Securities Maintains Buy on Arthur J. Gallagher, Raises Price Target to $220

By Benzinga Newsdesk

October 28, 8:28 AM

Truist Securities analyst Mark Hughes maintains Arthur J. Gallagher (NYSE:AJG) with a Buy and raises the price target from $210 to $220.

AJG

Boeing Cargo Plane’s Daring Gearless Landing In Istanbul, Investigation Underway

By Vandana Singh

May 8, 11:41 AM

Boeing 767 cargo plane makes emergency landing at Istanbul Airport due to front landing gear malfunction. No casualties reported. Turkish Transport Ministry investigates. FedEx pledges cooperation amid Boeing's management restructuring.

Rubric Capital Management Reports In 13D Filing A 9.9% Stake In Heron Therapeutics

Related Posts

XS Financial Enters Into Upsized $39M Credit Facility With Needham Bank

Canadian Pacific Kansas Provides Multi-Year Guidance; Plans New Direct CP-CSX Interchange Connection In Alabama

Truist Securities Maintains Buy on Arthur J. Gallagher, Raises Price Target to $220

Boeing Cargo Plane’s Daring Gearless Landing In Istanbul, Investigation Underway